Latest ALS (Lou Gehrig's Disease) news
Antisense Oligonucleotide Tofersen Reduces SOD1 in SOD1 ALS
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Antisense Oligonucleotide Tofersen Reduces SOD1 in SOD1 ALS
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves New ALS Drug Despite Uncertain Data
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves New ALS Drug Despite Uncertain Data
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Suspends U.S. License of Chikungunya Vaccine 
Hospital-Treated Infections Earlier in Life Tied to Alzheimer, Parkinson Disease Risk 
Occupational Exposures Tied to ALS Risk Monthly Specialist Briefings
Stay Connected
